Biofrontera returns to operating profit in H1 2026; revenue jumps 44% to EUR 9.04 million

Bitget2026/09/30 11:32

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

Biofrontera posted H1 2026 revenue of EUR 9.04 million, up 44% year over year.
EBITDA from continuing operations swung to EUR 1.74 million from a loss of EUR 1.26 million a year earlier.
Total result after income taxes turned to a profit of EUR 5.53 million from a loss of EUR 3.69 million.
Management said Germany revenue rose partly on temporary wholesaler stock-building ahead of the July Ameluz price increase.
2026 guidance reiterated: group revenue EUR 14-16 million, unadjusted EBITDA between EUR -0.5 million and +0.5 million.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Biofrontera AG published the original content used to generate this news brief via pressetext (Ref. ID: 202609300730PRESSTXTEUPR__DEC0D4576392982EDA2729EADFD2CB734) on September 30, 2026, and is solely responsible for the information contained therein.

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

Biofrontera returns to operating profit in H1 2026; revenue jumps 44% to EUR 9.04 million

You may also like

Crypto prices